Roche's (RHHBY) acquisition of Spark Therapeutics (ONCE) will likely close before the year ends, an analyst said after reports suggested U.S. regulators would bless the deal.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,